Tesla (TSLA) tumbled nearly 7% on Monday, July 7 as the electric vehicle giant grapples with declining deliveries and CEO ...

There has been a divergence in the fortunes of the “Magnificent 7” stocks this year. Tesla (TSLA), Alphabet (GOOG), and Apple ...

William Blair has downgraded its FY2025 earnings estimate for Tesla, now predicting a lower EPS of $1.05 compared to $1.38 ...

OPEC is sticking to its guns while everyone else is screaming climate emergency. The cartel now says global oil demand will hit 123 million barrels a day by ...

Earnings are expected to be around $0.44 per share, according to consensus estimates, reflecting a 15% drop compared to the ...

Despite these issues, Tesla investors appear to be convinced that the company will experience a surge in sales trends at some ...

The annual meeting will be in November, nearly four months after what is required under Texas law. Tesla said on Thursday ...

Tesla faces declining sales, intense competition, and overhyped ventures while leadership concerns grow and FSD lags peers.

Tesla finally announced the date of its annual meeting. That’s after dozens of angry shareholders asked what was taking it so long.

The global green hydrogen market is experiencing robust growth, projected to reach between USD 100 billion to USD 120 billion ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $5.72, marking a +2.24% move from the previous day.